Click a link below to view the mailing archive as if it had been sent to you.
| 2012-11-30 12:00 | | FDA Panel Turns Thumbs Down on Vibativ and more... |
| 2012-11-30 00:00 | | InterMune Gearing Up For Another Round With The FDA and more... |
| 2012-11-29 12:00 | | Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy and more... |
| 2012-11-28 12:00 | | 10 top drug launch disasters and more... |
| 2012-11-28 00:00 | | AstraZeneca, Pfizer partner on $100M drug research collaboration project and more... |
| 2012-11-27 12:00 | | Transcept, partner launch $29M ad campaign around sleep drug Intermezzo and more... |
| 2012-11-27 00:00 | | J&J preps case for quick FDA approval of new TB drug and more... |
| 2012-11-26 12:00 | | 3 Difficult-To-Understand Trends In Biotechnology and more... |
| 2012-11-26 00:00 | | The Easy Way to Make Millions on Biotechs and more... |
| 2012-11-25 13:15 | | Increased Insurance Coverage: A Big Step For Anti-Obesity Drug Manufacturers and more... |
| 2012-11-25 12:00 | | Increased Insurance Coverage: A Big Step For Anti-Obesity Drug Manufacturers and more... |
| 2012-11-25 00:00 | | 4 Pharmaceutical Stocks to Buy Now and more... |
| 2012-11-22 00:00 | | Armed with EU stroke approval, Pfizer, BMS talk up Eliquis' edge over rivals and more... |
| 2012-11-21 12:00 | | This Healthcare Giant Needs to Focus on Organic Growth and more... |
| 2012-11-21 00:00 | | TauRx nabs $112M to back Phase III Alzheimer's program and more... |
| 2012-11-20 00:00 | | First 90 Days of 2013 Are Live or Die For These Biotech Stocks and more... |
| 2012-11-19 12:00 | | Picking The Weight Loss Winner In The Arena Vs. Vivus War and more... |
| 2012-11-18 00:00 | | Teva, AstraZeneca reportedly competing to court Irish drug company Amarin and more... |
| 2012-11-16 12:00 | | Forest Inks Alzheimer's Drug Deal and more... |
| 2012-11-16 00:00 | | Trovagene's Foray Into The Conventions Of Molecular Diagnostics and more... |
| 2012-11-15 12:00 | | J&J, Lilly, Merck plan clinical trial site database and more... |
| 2012-11-15 00:00 | | Genzyme resolves shortage of cancer drug Thyrogen and more... |
| 2012-11-14 12:00 | | 'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production and more... |
| 2012-11-14 00:00 | | Promising Biotech Stocks With Upcoming FDA Catalysts and more... |
| 2012-11-13 12:00 | | J&J Ponders Elan Tie While Alzheimer Drug Future Reviewed and more... |
| 2012-11-13 00:00 | | Sequenom climbs after analyst sees progress on reimbursements and more... |
| 2012-11-12 12:00 | | Gilead Climbs on Study Results of Hepatitis C Combo and more... |
| 2012-11-11 12:00 | | Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus and more... |
| 2012-11-10 00:00 | | Industry Voices: The Impact of the 2012 Election on Pharma Is All about Product Value |
| 2012-11-09 12:00 | | The January Effect And 3 Biopharma Stocks and more... |
| 2012-11-09 00:00 | | Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection and more... |
| 2012-11-08 12:00 | | What Orexigen Is Saying -- and Not Saying and more... |
| 2012-11-08 00:00 | | NeoStem To Create Value With Billion Dollar Potential and more... |
| 2012-11-07 12:00 | | Merck May Not Have Shown Women Can Safely Choose Drug and more... |
| 2012-11-07 00:00 | | Buyout Buzz: The most frequently cited takeover targets in biotech and more... |
| 2012-11-06 12:00 | | FDA staff highlight heart risk with Novo insulin and more... |
| 2012-11-06 00:00 | | AmgenâÔö£é?öé??Ôö£é?ö?ñós Drug Lowers Cholesterol Among Statin Intolerant and more... |
| 2012-11-05 12:00 | | Arena Pharmaceuticals' Solution to a Billion Dollar a Day Problem and more... |
| 2012-11-04 12:00 | | Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary End... and more... |
| 2012-11-04 00:00 | | Medicis Pharmaceutical Larger Than S&P 500 Component Pitney Bowes and more... |
| 2012-11-03 00:00 | | Dendreon Corp Earnings: Revenue Grows Again by Double Digits, Investors Love These Numbers and more... |
| 2012-11-02 12:00 | | Arena And Vivus To Announce Earnings On Same Day - What To Expect and more... |
| 2012-11-02 00:00 | | Why Arena's Launch Will Be Strong, Despite Vivus' Weak Launch and more... |
| 2012-11-01 12:00 | | Isis Means Business With This New Treatment and more... |
| 2012-11-01 00:00 | | Exelixis, Celgene, Gilead Sciences, Dynavax See Key Dates in November and more... |
